Related content

Multi-Matrix System (MMX®) mesalamine for the treatment of mild-to-moderate ulcerative colitis

By Horst Sara N   Kane Sunanda  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 15, 2012-10 ,pp. : 2225-2232

Informa Healthcare

Access to resources Recommend Favorite

Delayed-Release Multi Matrix System (MMX™) Mesalazine: In Ulcerative Colitis

By McCormack Paul L.   Robinson Dean M.   Perry Caroline M.  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2635-2642

Adis International

Access to resources Recommend Favorite

Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis: A Viewpoint by Åke Nilsson

By Nilsson Åke  

Drugs, Vol. 67, Iss. 17, 2007-01 ,pp. : 2643-2644

Adis International

Access to resources Recommend Favorite

Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats

By Ahmadi Fatemeh   Varshosaz Jaleh   Emami Jaber   Tavakoli Naser   Minaiyan Mohsen   Mahzouni Parvin   Dorkoosh Farid  

Drug Delivery, Vol. 18, Iss. 2, 2011-02 ,pp. : 122-130

Informa Healthcare

Access to resources Recommend Favorite

Preparation of budesonide–dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis

By Varshosaz Jaleh   Emami Jaber   Ahmadi Fatemeh   Tavakoli Naser   Minaiyan Mohsen   Fassihi Afshin   Mahzouni Parvin   Dorkoosh Farid  

Journal of Drug Targeting, Vol. 19, Iss. 2, 2011-02 ,pp. : 140-153

Informa Healthcare

Access to resources Recommend Favorite